Circulating CAIX as a biomarker in breast cancer

被引：0
|
作者：
Brown-Glaberman, U.
Chalasani, P.
Livingston, R.
Lannone, M.
Marron, M.
Specht, J.
Stopeck, A.
机构：
[1] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA
[2] Univ Arizona, Ctr Canc, Tucson, AZ USA
[3] Fred Hutchinson Univ Washington, Canc Consortium, Seattle, WA USA
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P1-03-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-03-01
引用
收藏
页数：2
相关论文
共 50 条
  • [31] GDF15 is a candidate circulating biomarker of eribulin response in breast cancer.
    Bellio, Chiara
    Emperador, Marta
    Garrigos, Laia
    Zamora, Esther
    Saura, Cristina
    Littlefield, Bruce A.
    Villanueva, Josep
    CANCER RESEARCH, 2021, 81 (13)
  • [32] Gene profiling and circulating tumor cells as biomarker to prognostic of patients with locoregional breast cancer
    Kuniyoshi, Renata K.
    Gehrke, Flavia de Sousa
    Alves, Beatriz C. A.
    Vilas-Boas, Viviane
    Colo, Anna E.
    Sousa, Naiara
    Nunes, Joao
    Fonseca, Fernando L. A.
    Del Giglio, Auro
    TUMOR BIOLOGY, 2015, 36 (10) : 8075 - 8083
  • [33] Multiple Biomarker Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients
    Bruce, R. H.
    Hsieh, H. B.
    Bennis, R.
    Krivacic, R. T.
    Liu, X.
    Frankel, P.
    Lau, S.
    Somlo, G.
    CANCER RESEARCH, 2010, 70
  • [34] Expression profiling of circulating tumor cells: A prognostic and predictive biomarker in metastatic breast cancer
    Bredemeier, Maren
    Kubista, Mikael
    Sjoeback, Robert
    Jendrichova, Marie
    Rohlova, Eva
    Novosadova, Vednula
    Kolostova, Katarina
    Hauch, Siegfried
    Aktas, Bahriye
    Tewes, Mitra
    Kimmig, Rainer
    Kasimir-Bauer, Sabine
    CANCER RESEARCH, 2015, 75
  • [35] Potential Management of Circulating Tumor DNA as a Biomarker in Triple-Negative Breast Cancer
    Shang, Mao
    Chang, Chunxiao
    Pei, Yanqing
    Guan, Yin
    Chang, Jin
    Li, HuiHui
    JOURNAL OF CANCER, 2018, 9 (24): : 4627 - 4634
  • [36] Circulating SOD2 Is a Candidate Response Biomarker for Neoadjuvant Therapy in Breast Cancer
    Juliachs, Merce
    Pujals, Mireia
    Bellio, Chiara
    Meo-Evoli, Nathalie
    Duran, Juan M.
    Zamora, Esther
    Pares, Mireia
    Sunol, Anna
    Mendez, Olga
    Sanchez-Pla, Alex
    Canals, Francesc
    Saura, Cristina
    Villanueva, Josep
    CANCERS, 2022, 14 (16)
  • [37] Circulating cell-free miRNAs as biomarker for triple-negative breast cancer
    V Y Shin
    J M Siu
    I Cheuk
    E K O Ng
    A Kwong
    British Journal of Cancer, 2015, 112 : 1751 - 1759
  • [38] Circulating Tumor DNA as a Novel Biomarker Optimizing Treatment for Triple Negative Breast Cancer
    Sun, Yue
    Zhu, Chengjun
    Xu, Feng
    Cui, Shiyun
    Guan, Xiaoxiang
    CLINICAL BREAST CANCER, 2023, 23 (04) : 339 - 349
  • [39] VALIDATION OF THE CAIX SCORE AS A PROGNOSTIC BIOMARKER FOR LYMPHATIC SPREAD AND CANCER-SPECIFIC SURVIVAL
    Chamie, Karim
    Said, Jonathan
    Belldegrun, Arie S.
    Pantuck, Allan J.
    JOURNAL OF UROLOGY, 2014, 191 (04): : E383 - E383
  • [40] Circulating tumor cell count: A reliable biomarker for treatment selection in metastatic breast cancer
    Li, Bingzhen
    Zheng, Ying
    THORACIC CANCER, 2022, 13 (02) : 265 - 266
12345